Conference Coverage

DANCAVAS misses primary endpoint but hints at benefit from comprehensive CV screening

Publish date: August 27, 2022

 

AT ESC CONGRESS 2022

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

‘Obesity paradox’ in AFib challenged as mortality climbs with BMI
Journal of Clinical Outcomes Management
AHA statement outlines symptoms of common heart diseases
Journal of Clinical Outcomes Management
Does DTC heart drug advertising discourage lifestyle changes?
Journal of Clinical Outcomes Management
Cholesterol levels lowering in U.S., but disparities emerge
Journal of Clinical Outcomes Management
How much weight does my patient need to lose?
Journal of Clinical Outcomes Management
‘Conservative’ USPSTF primary prevention statin guidance finalized
Journal of Clinical Outcomes Management
NSAIDs linked to heart failure risk in diabetes
Journal of Clinical Outcomes Management
Early menopause linked with increased risk of heart problems
Journal of Clinical Outcomes Management
Congressman’s wife died after taking herbal remedy marketed for diabetes and weight loss
Journal of Clinical Outcomes Management
Secondary CV prevention benefit from polypill promises global health benefit
Journal of Clinical Outcomes Management